Remote Monitoring and Virtual Visits

In today’s remote and decentralized clinical trial environment, ensuring that all site personnel have completed the required training is more than a best practice—it is a regulatory mandate. With investigator meetings, SOP reviews, and protocol-specific instructions now delivered virtually, it is imperative for sponsors and CROs to implement reliable systems that track and document training completion in an auditable, inspection-ready format. This guide explains how to structure and maintain remote training completion tracking systems to meet FDA, EMA, and ICH expectations.

Click to read the full article.

As clinical trials become more complex and decentralized, ensuring that site personnel remain compliant over the study duration is critical. Training should not end at the investigator meeting or site initiation visit. Regulators, including the FDA, EMA, and MHRA, emphasize the importance of ongoing training—especially refresher training—to prevent protocol deviations, maintain GCP compliance, and prepare sites for audits or inspections. This article outlines how to plan, deliver, and document remote refresher training as part of an inspection-readiness strategy.

Click to read the full article.

In multinational clinical trials, one of the most persistent challenges is ensuring consistent training delivery and comprehension across geographically dispersed investigator sites. Regulatory authorities such as the FDA, EMA, and PMDA have raised inspectional concerns when discrepancies are noted between regions in how study protocols are implemented. This article presents a comprehensive guide to ensuring training uniformity, backed by real-world case studies and CAPA strategies that mitigate regulatory risks and enhance trial data integrity.

Click to read the full article.

Online training has become the cornerstone of clinical trial onboarding, protocol training, SOP dissemination, and regulatory updates. However, the value of any training is directly tied to how well it is received, understood, and applied. Feedback mechanisms serve as both a quality control tool and a regulatory compliance indicator. This tutorial presents practical strategies to implement feedback loops that not only assess training effectiveness but also meet FDA, EMA, and ICH-GCP requirements.

Click to read the full article.